REPORT ID 2716

United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017

Publish Date
11-Dec-17
Pages
107
Format
Electronic (PDF)

In this report, the United States Receptor Tyrosine Protein Kinase Targeted Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Receptor Tyrosine Protein Kinase Targeted Drugs in these regions, from 2012 to 2022 (forecast).

United States Receptor Tyrosine Protein Kinase Targeted Drugs market competition by top manufacturers/players, with Receptor Tyrosine Protein Kinase Targeted Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Aslan Pharmaceuticals Pte Ltd
    Boehringer Ingelheim GmbH
    GamaMabs Pharma SA
    Hanmi Pharmaceuticals Co Ltd
    Jiangsu Kanion Pharmaceutical Co Ltd
    Minerva Neurosciences Inc
    Pfizer Inc
    Puma Biotechnology Inc
    Shanghai Fosun Pharmaceutical (Group) Co Ltd
    XuanZhu Pharma Co Ltd
    Zensun (Shanghai) Sci & Tech Co Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Afatinib Dimaleate
    Dacomitinib
    Neratinib
    Neucardin
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Cardiovascular
    Central Nervous System
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Report 2017
1 Receptor Tyrosine Protein Kinase Targeted Drugs Overview
    1.1 Product Overview and Scope of Receptor Tyrosine Protein Kinase Targeted Drugs
    1.2 Classification of Receptor Tyrosine Protein Kinase Targeted Drugs by Product Category
        1.2.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Afatinib Dimaleate
        1.2.4 Dacomitinib
        1.2.5 Neratinib
        1.2.6 Neucardin
        1.2.7 Others
    1.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market by Application/End Users
        1.3.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Central Nervous System
        1.3.5 Others
    1.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market by Region
        1.4.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.3 Southwest Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.5 New England Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.6 The South Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
        1.4.7 The Midwest Receptor Tyrosine Protein Kinase Targeted Drugs Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Receptor Tyrosine Protein Kinase Targeted Drugs (2012-2022)
        1.5.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2012-2022)
        1.5.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Growth Rate (2012-2022)

2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Players/Suppliers
    2.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Average Price by Players/Suppliers (2012-2017)
    2.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation and Trends
        2.4.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Rate
        2.4.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Region (2012-2017)
    3.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Region (2012-2017)
    3.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Price by Region (2012-2017)

4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2012-2017)
    4.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2012-2017)
    4.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate by Type (2012-2017)

5 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume) by Application (2012-2017)
    5.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Market Share by Application (2012-2017)
    5.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Receptor Tyrosine Protein Kinase Targeted Drugs Players/Suppliers Profiles and Sales Data
    6.1 Aslan Pharmaceuticals Pte Ltd
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boehringer Ingelheim GmbH
        6.2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GamaMabs Pharma SA
        6.3.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Hanmi Pharmaceuticals Co Ltd
        6.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Jiangsu Kanion Pharmaceutical Co Ltd
        6.5.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Minerva Neurosciences Inc
        6.6.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Pfizer Inc
        6.7.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Puma Biotechnology Inc
        6.8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
        6.9.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 XuanZhu Pharma Co Ltd
        6.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Zensun (Shanghai) Sci & Tech Co Ltd

7 Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Analysis
    7.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Forecast by Type (2017-2022)
    11.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Forecast by Application (2017-2022)
    11.4 United States Receptor Tyrosine Protein Kinase Targeted Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer